Author
Listed:
- Chun-Wei Ho
(Intelligent Diabetes Metabolism and Exercise Center, China Medical University Hospital, Taichung 40447, Taiwan
Chun-Wei Ho and Hsin-Hung Chen are equally contributed to this article.)
- Hsin-Hung Chen
(Intelligent Diabetes Metabolism and Exercise Center, China Medical University Hospital, Taichung 40447, Taiwan
School of Medicine, Institute of Medicine and Public Health, Chung Shan Medical University, Taichung 40201, Taiwan
Chun-Wei Ho and Hsin-Hung Chen are equally contributed to this article.)
- Ming-Chia Hsieh
(Intelligent Diabetes Metabolism and Exercise Center, China Medical University Hospital, Taichung 40447, Taiwan
Division of Clinical Nutrition, China Medical University Hospital, Taichung 40447, Taiwan
Graduate Institute of Integrative Medicine, China Medical University, Taichung 40447, Taiwan)
- Ching-Chu Chen
(Division of Endocrinology and Metabolism, Department of Internal Medicine, China Medical University Hospital, Taichung 40447, Taiwan
School of Chinese Medicine, China Medical University, Taichung 40447, Taiwan)
- Sheng-Pang Hsu
(Division of Endocrinology and Metabolism, Department of Internal Medicine, China Medical University Hospital, Taichung 40447, Taiwan)
- Hei-Tung Yip
(Management Office for Health Data, China Medical University Hospital, Taichung 40447, Taiwan
College of Medicine, China Medical University, Taichung 40447, Taiwan)
- Chia-Hung Kao
(Graduate Institute of Biomedical Sciences and School of Medicine, College of Medicine, China Medical University, Taichung 40447, Taiwan
Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung 40447, Taiwan
Department of Bioinformatics and Medical Engineering, Asia University, Taichung 40447, Taiwan
Center of Augmented Intelligence in Healthcare, China Medical University Hospital, Taichung 40447, Taiwan)
Abstract
Objective: To investigate the prevalence of polycystic ovary syndrome (PCOS) and its comorbidities in patients with autoimmune thyroid disease (AITD). Population: In this cohort study, patients newly diagnosed as having Hashimoto thyroiditis (HT) or Grave disease (GD) were recruited into the AITD group. Method: The logistic regression model was used to investigate the association between exposure, endpoint, later diseases and treatment. Main Outcome Measures: We assessed the cumulative incidence using the Kaplan–Meier method and verified the difference by the log-rank test. Results: The AITD group included 3599 GD patients and 1332 HT patients. PCOS risk in patients with AITD was higher than that in the control group (adjusted hazard ratio = 1.39; 95% confidence interval = 1.07–1.71). In patients with both AITD and PCOS, the odds ratios of diabetes, hyperlipidemia and coronary artery disease were 2.48, 2.05 and 2.63, respectively. Conclusions: The risks of PCOS and its comorbidities such as diabetes, dyslipidemia and cardiac artery disease are high in patients with AITD in Taiwan.
Suggested Citation
Chun-Wei Ho & Hsin-Hung Chen & Ming-Chia Hsieh & Ching-Chu Chen & Sheng-Pang Hsu & Hei-Tung Yip & Chia-Hung Kao, 2020.
"Increased Risk of Polycystic Ovary Syndrome and It’s Comorbidities in Women with Autoimmune Thyroid Disease,"
IJERPH, MDPI, vol. 17(7), pages 1-8, April.
Handle:
RePEc:gam:jijerp:v:17:y:2020:i:7:p:2422-:d:340568
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:7:p:2422-:d:340568. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.